07/16/21UCSD 3D 'Assembloid' Shows How SARS-CoV-2 Infects Brain Cells Researchers at UC San Diego School of Medicine and Rady Children’s Institute for Genomic Medicine have produced a stem cell model that demonstrates a potential route of entry of SARS-CoV-2, the virus ... Read more

07/12/21UCSD Selective, Toxin-Bearing Antibodies Could Help Treat Liver Fibrosis UC San Diego researchers discovered that immunotoxins targeting the protein mesothelin prevent liver cells from producing collagen, a precursor to fibrosis and cirrhosis, in mouse models of human dise ... Read more

07/06/21UCSD Colorectal Cancer Risk May Increase with Lower Exposure to UVB Light University of California San Diego School of Medicine researchers identified a possible link between inadequate exposure to ultraviolet-B (UVB) light from the sun and an increased risk of colorectal c ... Read more

07/02/21UCSD Potential Drug Target for Difficult-To-Treat Breast Cancer: RNA-Binding Proteins UC San Diego studies using human cell lines and tumors grown in mice provide early evidence that inhibiting RNA-binding proteins, a previously overlooked family of molecules, might provide a new appro ... Read more

06/22/21UCSD Iris and Matthew Strauss Give $2 Million to Endow Faculty Chair at UC San Diego Longtime supporters of cancer research and patient care at Moores Cancer Center at UC San Diego Health have given University of California San Diego School of Medicine $2 million to establish the Iris ... Read more

06/18/21Sanford Burnham Prebys Researchers dig deeper into how cells transport their waste for recycling Press Release Read more

06/17/21UCSD How Cells 'Read' Artificial Ingredients Tossed into Genetic Recipe UC San Diego School of Medicine researchers discovered that the enzyme RNA polymerase II recognizes and transcribes artificially added base pairs in genetic code, a new insight that could help advance ... Read more

06/10/21Salk Institute “Bad fat” suppresses killer T cells from attacking cancer LA JOLLA—In order for cancer to grow and spread, it has to evade detection by our immune cells, particularly specialized “killer” T cells. Salk researchers led by Professor Susan Kaech have found that the environment inside tumors (the tumor microenvironment) contains an abundance of oxidized fat molecules, which, when ingested by the killer T cells, suppresses their ability to kill cancer cells. In a vicious cycle, those T cells, in need of energy, increase the level of a cellular fat transporter, CD36, that unfortunately saturates them with even more oxidized fat and further curtails their anti-tumor functions. Read more

06/07/21Salk Institute Research advances one step closer to stem cell therapy for type 1 diabetes LA JOLLA—Type 1 diabetes, which arises when the pancreas doesn’t create enough insulin to control levels of glucose in the blood, is a disease that currently has no cure and is difficult for most patients to manage. Scientists at the Salk Institute are developing a promising approach for treating it: using stem cells to create insulin-producing cells (called beta cells) that could replace nonfunctional pancreatic cells. Read more

06/03/21UCSD UC San Diego Health Begins Treating Multiple Myeloma with CAR T-cell Therapy As the first designated medical center in San Diego certified to offer this type of immunotherapy, UC San Diego Health will begin treating patients this month. Read more

06/01/21UCSD Diet Plays Critical Role in NASH Progressing to Liver Cancer in Mouse Model Researchers at UC San Diego School of Medicine found in a mouse model that when fed a Western diet rich in calories, fat and cholesterol, the mice progressively became obese, diabetic and developed NA ... Read more

05/27/21UCSD Noted Researcher and Scientific Leader Jack E. Dixon Retires Jack E. Dixon, whose distinguished and varied 48-year career ranged from helping reveal how cells communicate to becoming a renowned scientific leader at UC San Diego School of Medicine and Howard Hug ... Read more

05/25/21Salk Institute New study shows how to boost muscle regeneration and rebuild tissue LA JOLLA—One of the many effects of aging is loss of muscle mass, which contributes to disability in older people. To counter this loss, scientists at the Salk Institute are studying ways to accelerate the regeneration of muscle tissue, using a combination of molecular compounds that are commonly used in stem-cell research. Read more

05/20/21UCSD UC San Diego Health Joins Call to Don’t Delay HPV Vaccinations, Save Lives Moores Cancer Center at UC San Diego Health joins other National Cancer Institute cancer centers in urging that HPV vaccinations get back on track as part of cancer prevention. Don’t delay. Save lives ... Read more

05/19/21UCSD Genetic Tools Help Identify a Cellular Culprit for Type 1 Diabetes By mapping its genetic underpinnings, researchers at University of California San Diego School of Medicine have identified a predictive causal role for specific cell types in type 1 diabetes, a condit ... Read more

05/18/21Salk Institute Salk scientists reveal role of genetic switch in pigmentation and melanoma LA JOLLA—Despite only accounting for about 1 percent of skin cancers, melanoma causes the majority of skin cancer-related deaths. While treatments for this serious disease do exist, these drugs can vary in effectiveness depending on the individual. Read more

05/13/21UCSD Hanna and Mark Gleiberman Give $12 Million to UC San Diego Hanna and Mark Gleiberman give $12 Million to UC San Diego to support the internationally recognized head and neck cancer center at UC San Diego Health. Funding will support research and patient exper ... Read more

04/30/21Salk Institute The novel coronavirus’ spike protein plays additional key role in illness LA JOLLA—Scientists have known for a while that SARS-CoV-2’s distinctive “spike” proteins help the virus infect its host by latching on to healthy cells. Now, a major new study shows that the virus spike proteins (which behave very differently than those safely encoded by vaccines) also play a key role in the disease itself. Read more

04/28/21UCSD How SARS-CoV-2 Hijacks Human Cells to Evade Immune System UC San Diego School of Medicine researchers discovered one way in which SARS-CoV-2 hijacks human cell machinery to blunt the immune response, allowing it to establish infection, replicate and cause di ... Read more

04/27/21Salk Institute Salk scientists reveal how brain cells in Alzheimer’s go awry, lose their identity LA JOLLA—Despite the prevalence of Alzheimer’s, there are still no treatments, in part because it has been challenging to study how the disease develops. Now, scientists at the Salk Institute have uncovered new insights into what goes awry during Alzheimer’s by growing neurons that resemble—more accurately than ever before—brain cells in older patients. And like patients themselves, the afflicted neurons appear to lose their cellular identity. Read more

04/26/21UCSD Genetic Changes in Head and Neck Cancer, Immunotherapy Resistance Identified A multi-institutional team of researchers, led by UC San Diego School of Medicine and Moores Cancer Center, has identified both the genetic abnormalities that drive pre-cancer cells into becoming an i ... Read more

04/22/21Salk Institute Researchers trace spinal neuron family tree LA JOLLA—Spinal cord nerve cells branching through the body resemble trees with limbs fanning out in every direction. But this image can also be used to tell the story of how these neurons, their jobs becoming more specialized over time, arose through developmental and evolutionary history. Salk researchers have, for the first time, traced the development of spinal cord neurons using genetic signatures and revealed how different subtypes of the cells may have evolved and ultimately function to regulate our body movements. Read more

04/21/21Salk Institute San Diego Nathan Shock Center announces first grant awardees at inaugural training workshop LA JOLLA—The San Diego Nathan Shock Center (SD-NSC) of Excellence in the Basic Biology of Aging, a consortium between the Salk Institute for Biological Studies, Sanford Burnham Prebys (SBP) Medical Discovery Institute and the University of California San Diego, has announced the first class of pilot grant awardees at the center’s inaugural training workshop. Six recipients, each from a different institution, will receive up to $15,000 to pursue research that advances our understanding of how humans age, with the ultimate goal of extending the number of years of healthy, disease-free life (i.e., health span). Read more

04/19/21UCSD How Brain Tumors Turn Immune Cells into Cancer-Growing Hostages Researchers discover that brain cancer tumors reprogram immune cells to help them grow, rather than suppress them. Read more

04/15/21Salk Institute Chimeric tool advanced for wide range of regenerative medicine, biomedical research applications LA JOLLA—The ability to grow the cells of one species within an organism of a different species offers scientists a powerful tool for research and medicine. It’s an approach that could advance our understanding of early human development, disease onset and progression and aging; provide innovative platforms for drug evaluation; and address the critical need for transplantable organs. Yet developing such capabilities has been a formidable challenge. Read more

04/15/21UCSD Study Uses Precision Medicine to Speed Drug Testing for Pancreatic Cancer Moores Cancer Center at UC San Diego Health is among the few clinical trial sites in the U.S. for the Pancreatic Cancer Action Network’s (PanCAN) newly created Precision Promise, the first large-scale ... Read more

04/14/21UCSD Autism Center at UC San Diego Receives $1.5 Million Gift The UC San Diego Autism Center for Excellence has received a $1.5 million gift from Kristin Farmer, founder and chief executive officer of ACES, a company that provides services to children with autis ... Read more

04/02/21UCSD Experimental Therapy for Parasitic Heart Disease May Also Help Stop COVID-19 UC San Diego researchers found that the chemical inhibitor K777 reduces the coronavirus’ ability to infect cell lines by blocking human enzyme cathepsin L; clinical trials are underway. Read more

03/24/21UCSD Repurposed Heart and Flu Drugs May Help Body Fight Sepsis UC San Diego researchers discovered that patient survival from sepsis is associated with higher platelet counts, and identified two currently available drugs that protect these blood cells and improve ... Read more

03/18/21UCSD Reversing Cancer’s Gluttony Researchers at UC San Diego School of Medicine and Moores Cancer Center describe how pancreatic cancer cells use an alternative method to find necessary nutrients, defying current therapies, to help t ... Read more

03/09/21UCSD Therapy Sneaks into Hard Layer of Pancreatic Cancer Tumor and Destroys it From Within Researchers at University of California San Diego School of Medicine and Moores Cancer Center demonstrated that a new tumor-penetrating therapy could enhance the effects of chemotherapy, reduce the sp ... Read more

02/24/21UCSD Human Lung and Brain Organoids Respond Differently to SARS-CoV-2 Infection in Lab Tests UC San Diego School of Medicine researchers are using stem cell-derived organoids to study how SARS-CoV-2 interacts with various organ systems. Their findings may help explain the wide variety in COVI ... Read more

02/23/21UCSD Genetic Tool Improves Estimation of Prostate Cancer Risk in Diverse Ethnic/Racial Groups Scientists at University of California San Diego School of Medicine validated a more inclusive and comprehensive genetic tool, known as a polygenic hazard score (PHS), for predicting age of onset of a ... Read more

02/18/21UCSD Chatter Between Cell Populations Drives Progression of Gastrointestinal Tumors Researchers at University of California San Diego School of Medicine identified new therapeutic targets for gastrointestinal stromal tumors (GISTs) that could lead to new treatment options for patient ... Read more

02/18/21UCSD Genetics May Play Role in Determining Immunity to COVID-19 UC San Diego researchers report that individual immune response to SARS-CoV-2 may be limited by a set of variable genes that code for cell surface proteins essential for the adaptive immune system. Th ... Read more

02/02/21UCSD Year or More Delay Between Abnormal, At-Home Screening and Colonoscopy Increases Cancer Risk A new study by researchers at University of California San Diego School of Medicine found delayed time between abnormal stool-based screening and subsequent colonoscopy was associated with an increase ... Read more

01/26/21UCSD Two Anti-viral Enzymes Transform Pre-Leukemia Stem Cells into Leukemia Viral infections and space travel similarly trigger inflammation and the enzymes APOBEC3C and ADAR1; UC San Diego researchers are developing ways to inhibit them as a means to potentially lower cancer ... Read more

01/25/21UCSD When — Not What — Obese Mice Ate Reduced Breast Cancer Risk University of California San Diego School of Medicine and Moores Cancer Center researchers report that intermittent fasting reduced breast cancer risk in obese mice. Read more

01/20/21UCSD Designer DNA Therapeutic Wipes Out Cancer Stem Cells, Treats Multiple Myeloma in Mice UC San Diego study supports launch of Phase I clinical trial to test a designer DNA agent — an antisense oligonucleotide that targets a gene called IRF4 — in patients with multiple myeloma. Read more

01/07/21UCSD Study: E-Cigarettes Trigger Inflammation in the Gut Chemicals used for vaping break down zipper-like junctions between cells in the gut, leading to chronic inflammation and potential for other health concerns. Read more